Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer

The safety and sensitivity of a telemetric capsule to monitor gastrointestinal hydrogen production in vivo in healthy subjects: a pilot trial comparison to concurrent breath analysis

(2018) Kyle J. Berean et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ingestible Sensors

(2017) Kourosh Kalantar-zadeh et al.   ACS Sensors

Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach

(2016) A. Baranska et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Microbial production of propanol

(2016) Thomas Walther et al.   BIOTECHNOLOGY ADVANCES

Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests

(2016) Le-Le Song et al.   World Journal of Gastrointestinal Oncology

Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up

(2015) Donato F. Altomare et al.   ANNALS OF SURGERY

Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know

(2015) Jill Tinmouth et al.   GUT

MetaboAnalyst 3.0—making metabolomics more meaningful

(2015) Jianguo Xia et al.   NUCLEIC ACIDS RESEARCH

Use of the Analysis of the Volatile Faecal Metabolome in Screening for Colorectal Cancer

(2015) Claire A Batty et al.   PLoS One

Urinary Volatile Organic Compounds for the Detection of Prostate Cancer

(2015) Tanzeela Khalid et al.   PLoS One

Review article: next generation diagnostic modalities in gastroenterology - gas phase volatile compound biomarker detection

(2014) R. P. Arasaradnam et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

An updated Asia Pacific Consensus Recommendations on colorectal cancer screening

(2014) J J Y Sung et al.   GUT

Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test

(2014) Manuel Zorzi et al.   GUT

Adenoma Detection Rate and Risk of Colorectal Cancer and Death

(2014) Douglas A. Corley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of Colorectal Cancer (CRC) by Urinary Volatile Organic Compound Analysis

(2014) Ramesh P. Arasaradnam et al.   PLoS One

Colorectal cancer prevention in Europe: Burden of disease and status of screening programs

(2014) E. Altobelli et al.   PREVENTIVE MEDICINE

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

(2013) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients

(2013) Na Wu et al.   MICROBIAL ECOLOGY

The National Health Service Bowel Cancer Screening Program: the early years

(2013) Colin J Rees et al.   Expert Review of Gastroenterology & Hepatology

Exhaled volatile organic compounds identify patients with colorectal cancer

(2012) D. F. Altomare et al.   BRITISH JOURNAL OF SURGERY

Metab: an R package for high-throughput analysis of metabolomics data generated by GC-MS

(2011) R. Aggio et al.   BIOINFORMATICS

Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma

(2011) M. Castellarin et al.   GENOME RESEARCH

Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests

(2011) Richard F A Logan et al.   GUT